Tragara Pharmaceuticals Garners $5,000,000 Series B Funding

  • Feed Type
  • Date
    2/8/2010
  • Company Name
    Tragara Pharmaceuticals
  • Mailing Address
    10955 Vista Sorrento Parkway San Diego, CA 92130
  • Company Description
    Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Tragara launched operations in January 2007 and is focusing its development resources on two programs: (1) TP1001 for the treatment of inflammation related disorders and (2) TP2001 for the treatment of solid tumors.
  • Website
    http://www.tragarapharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Mitsubishi Corporation
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    ProQuest Investments

By posting a comment, you agree to our terms and conditions.